New York State Common Retirement Fund
DMAC icon

New York State Common Retirement Fund’s DiaMedica Therapeutics DMAC Stock Holding History

New York State Common Retirement Fund’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.8K Sell
2,781
-9,019
-76% -$71.5K ﹤0.01% 3017
2025
Q4 		$93.9K Hold
11,800
– – ﹤0.01% 2630
2025
Q3 		$81.1K Sell
11,800
-14,500
-55% -$78.7K ﹤0.01% 2739
2025
Q2 		$103K Buy
+26,300
New +$103K ﹤0.01% 2615

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

New York State Common Retirement Fund's DMAC Position: Q1 2026 in Review

New York State Common Retirement Fund reduced its DiaMedica Therapeutics (DMAC) stake by 76% in Q1 2026, selling an estimated $71.5K and leaving 2,781 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

New York State Common Retirement Fund first reported a position in DMAC in Q2 2025 and has held it in 4 quarters since. The position peaked at $103K in Q2 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • New York State Common Retirement Fund held 2,781 shares of DiaMedica Therapeutics worth $18.8K as of Q1 2026.
  • New York State Common Retirement Fund sold 9,019 DiaMedica Therapeutics shares in Q1 2026, an estimated $71.5K.
  • DiaMedica Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #3017 holding.
  • New York State Common Retirement Fund first reported a position in DiaMedica Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • New York State Common Retirement Fund's DiaMedica Therapeutics position peaked at $103K in Q2 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.